Andrew Yang says that decriminalizing opioids and legalizing “certain drugs” is one tool that can be used to undermine international drug cartels and reduce violence associated with the illicit drug trade.
In an interview published last week, the 2020 Democratic presidential candidate was pressed on his plan to address cartels operating below the U.S.’s Southern border, and he said that “one approach we could take that would change the resources available to the cartels [is to] explore the legalization of certain drugs.”
“I’m open to looking at legalizing different drugs that are not just fueling the cartel but also in some cases would frankly be an upgrade over the opiates that many Americans are currently getting addicted to,” he said.
While Yang used the term “legalization,” which would imply some kind of regulatory scheme for controlled substances, he later clarified this his proposal for opioids would not involve making drugs like heroin commercially available. Rather, it would focus on removing the threat of jail time for simple possession and diverting people with substance misuse issues to treatment.
On the other hand, he told the H3 Podcast that legalizing marijuana “is the easy one” and also said his agenda would involve reforming federal laws around psilocybin mushrooms and other psychedelics, despite the fact that those substances are “not a huge economic driver of the cartels.”
Earlier this month, in a tweet, Yang said that he wants to make psychedelic mushrooms “more freely available,” especially for military veterans.
In the new podcast interview, Yang called decriminalizing opioids “the most dramatic” aspect of his drug policy plan.
“I’m actually looking to decriminalize opiates for personal use because we have eight Americans dying of drug overdoses every hour in this country,” he said. We’ve essentially initiated this massive opiate addiction plague, and it was a disease of capitalism. It started off [with] Purdue Pharma prescribing OxyContin and saying it’s a non-addictive wonder drug.”
“What happened was OxyContin addiction morphed into fentanyl and heroin and then a lot of that is what’s getting trafficked now,” he said. “We’ve created this nation of addicts, and they’ve actually found that OxyContin is now harder to get ahold off than the illegal stuff so you have this massive drug trade and it’s driving the resources.”
“What I’m proposing is we legalize opiates for personal use, which means if we catch you with the drugs, you get the drugs taken away from you but we don’t send you to jail, we send you to treatment and counseling and then we set up safe injection sites and safe consumption sites in the U.S. that are controversial, but they’ve been proven to work and save lives. If you did this, you could bring in some of this drug use out of the shadows and then get your user base down and then get the economic resources that are going to the cartels down.”
Asked where individuals would obtain illicit drugs under his proposed decriminalization model, Yang acknowledged that the source wouldn’t change but that the goal would be to decrease demand and resulting rates of substance misuse and overdoses.
“Right now they’re buying it from dealers, and then in my new world, they’d still be buying it from dealers. The dealers still go to jail. It’s just that the individual users don’t get sent to jail with the dealer,” he said. “You have to try to attack demand.”
Several Democratic presidential candidates have broadened their drug policy platform to include decriminalization of drugs beyond cannabis. South Bend, Indiana Mayor Pete Buttigieg and Rep. Tulsi Gabbard (D-HI), for example, have said that personal possession of any drug should not result in incarceration.
Yang’s perspective on maintaining criminalization for those selling the drugs has recently been disputed by the advocacy group the Drug Policy Alliance, which issued a report earlier this month arguing that taking such an approach makes illicit substances cheaper and more dangerous, and it also ignores the reality that many involved in drug selling suffer from addiction as well.
In any case, the candidate went on to again characterize the opioid crisis as a problem created by profit-minded drug companies.
“This is a disease where the government essentially turned a blind eye and let a drug company kill tens of thousands of Americans for profit, and now we’re left with the mess and the bill and it’s a human toll,” he said. “And it’s fueling what’s happening with the drug cartels because this is the majority of their business.”
Photo courtesy of YouTube/H3 Podcast.
New York Legal Marijuana Push ‘Effectively Over’ For 2020, Governor Says
New York Gov. Andrew Cuomo (D) conceded on Saturday that it’s unlikely marijuana will be legalized in the state this year.
“Marijuana and the gig economy were two of the more complicated initiatives that we wanted to work through that we didn’t get a chance to do,” he said in response to a question about which policy issues he would’ve liked to tackle in the annual budget bill that passed this week.
“Is the session effectively over? It’s up to the legislature, but I think it’s fair to say it’s effectively over,” he added, noting that several state lawmakers have been infected with coronavirus.
(Marijuana Moment’s editor provides some content to Forbes via a temporary exclusive publishing license arrangement.)
Congresswoman Wants Ban On DC Marijuana Sales Lifted Through Coronavirus Legislation
A congresswoman is calling on the government to end a policy prohibiting Washington, D.C. from legal marijuana sales, arguing that the jurisdiction is in particular need of tax revenue from cannabis commerce due to the coronavirus outbreak.
Rep. Eleanor Holmes Norton (D-DC) has repeatedly condemned the congressional rider barring the District of Columbia from allowing retail sales that has been extended each year since 2014, shortly after local voters approved a ballot measure to legalize low-level possession and home cultivation. But given the need for resources to combat the pandemic, she said a reversal of the provision should be included in the next COVID-related relief bill.
“At this moment of unparalleled need, D.C. should be able to collect tax revenue from all available sources, like every other jurisdiction, including from recreational marijuana, which is believed to be widely used in the District,” the congresswoman said in a press release on Friday, adding that D.C. was shorted in the last stimulus because Congress treated it as a territory rather than a state.
“While I am working for a retroactive fix in the next coronavirus bill, it is imperative that Congress also repeal the D.C. recreational marijuana commercialization rider in the next bill to help D.C. shore up its finances,” she said. “It is beyond unreasonable that congressional interference keeps only the District from commercializing recreational marijuana, while all other jurisdictions are free to do so.”
— Eleanor Holmes Norton (@EleanorNorton) April 3, 2020
“Bringing the District in line with other jurisdictions would create a critical source of tax revenue in our time of need.”
Last year, the House approved an appropriations bill that excluded the D.C. rider, but it was included in the Senate version and ultimately made its way into the final package that the president signed. The cannabis commerce ban was also included in President Trump’s budget proposal earlier this year.
“True to form, Representative Eleanor Holmes Norton continues to be one of the best allies to the cannabis reform movement,” Justin Strekal, political director for NORML, told Marijuana Moment. “During this unprecedented COVID-19 outbreak, it is critical that lawmakers analyze and reform any and every aspect of public policy to mitigate the health crisis and build a foundation for a strong recovery.”
“As the majority of states that regulate cannabis have deemed the industry essential to the continued functioning of their jurisdictions, the continued congressional prohibition of the District of Columbia enacting it’s own adult-use program becomes even more ridiculous,” he added.
Norton, in an interview about her push, said that the congressionally mandated prohibition on sales doesn’t prevent people from accessing cannabis but does block the city from collecting tax revenue.
“You can buy two ounces but, by the way you’ve got to do that on the black market,” she told WUSA-TV. “But there’s nobody to tax it. And I’m simply trying to get the taxes the District is due for merchandise, in this case marijuana that’s being consumed readily in the District of Columbia.”
🟢🟢 LEGALIZING COMMERCIAL MARIJUANA IN D.C. 🟢🟢
I spoke to D.C.'s Delegate @EleanorNorton
She's pushing for fully legal commercial marijuana sales in the District in a 4th Congressional stimulus package.
The District needs the money.
And people are smoking weed anyway. pic.twitter.com/PL9yoDKlrj
— Adam Longo (@adamlongoTV) April 3, 2020
Legislative priorities for Congress have shifted significantly as lawmakers attempt to address the outbreak, and that’s meant putting some reform efforts on hold. However, the issue isn’t being ignored entirely, and it’s possible that other members may look to attach modest marijuana proposals to additional coronavirus legislation.
For example, Rep. Katherine Clark (D-MA) said this week that U.S. Department of Veterans Affairs policy preventing its doctors from recommending medical cannabis in legal states puts service members at risk in Massachusetts because the state is shuttering recreational shops (but not medical dispensaries) and some veterans fear registering as patients out of concern that they could lose federal benefits.
Eleven senators wrote a letter to Appropriations Committee leadership asking that they allow small cannabis businesses to access federal loans and disaster relief programs. While the lawmakers said it should be enacted through an annual spending bill, advocates have argued that the policy change should be pursued through coronavirus legislation since these businesses are facing challenges just like those experienced by many other companies during the pandemic.
Photo courtesy of WeedPornDaily.
North Dakota Activists Say Marijuana Legalization Initiative Unlikely In 2020 Due To Coronavirus
North Dakota activists announced on Thursday that they are suspending their campaign put marijuana legalization on the November ballot due to the coronavirus outbreak.
In a Facebook post, Legalize ND said “we are going to have to face a few hard realities going forward” as businesses are shuttering, public events are being cancelled and individuals are encouraged to shelter in place. The pandemic means in-person signature gathering can’t take place, and the state does not allow for alternative signing options such as by mail or online.
“Due to the virus all of our major avenues for signature collection have been cancelled or indefinitely postponed, and going door to door is not safe for both those knocking and those getting knocked,” the group said. “Businesses will continue to collect, but we don’t want to create another vector for the coronavirus. As a result, at this time if something major doesn’t change we will not be able to make the 2020 ballot.”
Legalize ND said there’s no way for state policies related to signature gathering to be changed ahead of the November election. They needed to collect 13,452 valid signatures from voters before July 6 in order to qualify. In all likelihood, the campaign said it would have to shift its focus to the July 2022 primary election.
“This isn’t the solution we want, but given the situation it is what will have to happen,” the post states. “Stay safe, and hopefully we can make a major push when the quarantine ends.”
The proposed initiative would allow individuals to purchase and possess up to two ounces of cannabis. Unlike a much more far-reaching measure the same group pushed in 2018 that included no possession or cultivation limits, which voters rejected, this version would prohibit home growing, impose a 10 percent excise tax and establish a regulatory body to approve licenses for marijuana businesses.
North Dakota voters approved a medical cannabis initiative in 2016.
The coronavirus outbreak has dealt several blows to drug policy reform efforts in recent weeks.
Likewise in Washington, D.C., advocates for a measure to decriminalize psychedelics asked the mayor and local lawmakers to accept online signatures for their ballot petition.
In Oregon, advocates for a measure to decriminalize drug possession and a separate initiative to legalize psilocybin for therapeutic purposes have suspended in-person campaign events amid the pandemic.
In New York, Gov. Andrew Cuomo (D) recently conceded that legalization was “not likely” going to happen through the budget, as he hoped. Coronavirus shifted legislative priorities, and comprehensive cannabis reform seems to have proved too complicated an issue in the short-term.
Idaho activists announced on Thursday that they are suspending their campaign, though they are still “focusing on distributing petitions through online download at IdahoCann.co and encouraging every volunteer who has downloaded a petition to get them turned in to their county clerk’s office by mail, regardless of how many signatures they have collected.”
Finally, in Arizona, a legalization campaign is petitioning the state Supreme Court to instruct the secretary of state to allow individuals to sign ballot petitions digitally using an existing electronic system that is reserved for individual individual candidates seeking public office.
Photo courtesy of Philip Steffan.